The purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).
Signed informed consent
Adult, male or female, aged 18 or over
Patient with a malignant tumor of the oral cavity, oropharynx, hypopharynx, larynx, sinuses, or salivary glands, regardless of lymph node status (any N) M0, operable
Member or beneficiary of a social security plan
Child-Pugh C liver failure
Patients under guardianship, conservatorship, or legal protection
Patients deprived of their liberty
Pregnant or breastfeeding women